Identification of OncoMir Biomarkers: Comprehensive Analysis of Fatty Acid Pathway Genes in Colorectal Cancer Progression and Their Prognostic Implications.
Andisheh Oroujalian, Maryam Keshani, Farnoush Panahi, Mohadeseh Esmaeili, Zahra Koveitypour, Shahrzad Tabrizchi, Hamed Akbari, Mina Amiri, Maryam Esmaeili, Maryam Peymani, Farzad Seyed Forootan, Mohammad Hossein Nasr Esfahani, Kamran Ghaedi
{"title":"Identification of OncoMir Biomarkers: Comprehensive Analysis of Fatty Acid Pathway Genes in Colorectal Cancer Progression and Their Prognostic Implications.","authors":"Andisheh Oroujalian, Maryam Keshani, Farnoush Panahi, Mohadeseh Esmaeili, Zahra Koveitypour, Shahrzad Tabrizchi, Hamed Akbari, Mina Amiri, Maryam Esmaeili, Maryam Peymani, Farzad Seyed Forootan, Mohammad Hossein Nasr Esfahani, Kamran Ghaedi","doi":"10.1007/s12291-024-01261-5","DOIUrl":null,"url":null,"abstract":"<p><p>MicroRNAs play a pivotal role in driving colorectal cancer (CRC) progression through their influence on gene expression. In this study, we conducted a comprehensive analysis of gene expression profiles in CRC cell lines, focusing on the genes involved in the fatty acid pathway and their associated microRNAs. Our analysis unveiled a consistent pattern of decreased expression for miR-16-5p, miR-195-5p, miR-27a-3p, and miR-497-5p across all CRC cell lines studied. Intriguingly, the targeted genes showed a contrasting trend, with increased expression levels. To reinforce our findings, we conducted a comparative analysis with The Cancer Genome Atlas database, which corroborated our results. Notably, we found a strong association between high expression levels of PPARD and VEGFA and a shorter Disease-Free Survival (DFS) in CRC patients. Conversely, elevated expression of PPARGC1A was linked to better overall survival outcomes. These findings underscore the significant impact of microRNAs on the regulation of gene expression in colorectal cancer and highlight potential biomarkers for assessing disease progression and patient outcomes.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s12291-024-01261-5.</p>","PeriodicalId":13280,"journal":{"name":"Indian Journal of Clinical Biochemistry","volume":"41 4","pages":"519-532"},"PeriodicalIF":1.5000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13396109/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Clinical Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12291-024-01261-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/8/28 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
MicroRNAs play a pivotal role in driving colorectal cancer (CRC) progression through their influence on gene expression. In this study, we conducted a comprehensive analysis of gene expression profiles in CRC cell lines, focusing on the genes involved in the fatty acid pathway and their associated microRNAs. Our analysis unveiled a consistent pattern of decreased expression for miR-16-5p, miR-195-5p, miR-27a-3p, and miR-497-5p across all CRC cell lines studied. Intriguingly, the targeted genes showed a contrasting trend, with increased expression levels. To reinforce our findings, we conducted a comparative analysis with The Cancer Genome Atlas database, which corroborated our results. Notably, we found a strong association between high expression levels of PPARD and VEGFA and a shorter Disease-Free Survival (DFS) in CRC patients. Conversely, elevated expression of PPARGC1A was linked to better overall survival outcomes. These findings underscore the significant impact of microRNAs on the regulation of gene expression in colorectal cancer and highlight potential biomarkers for assessing disease progression and patient outcomes.
Supplementary information: The online version contains supplementary material available at 10.1007/s12291-024-01261-5.
期刊介绍:
The primary mission of the journal is to promote improvement in the health and well-being of community through the development and practice of clinical biochemistry and dissemination of knowledge and recent advances in this discipline among professionals, diagnostics industry, government and non-government organizations. Indian Journal of Clinical Biochemistry (IJCB) publishes peer reviewed articles that contribute to the existing knowledge in all fields of Clinical biochemistry, either experimental or theoretical, particularly deal with the applications of biochemistry, molecular biology, genetics, biotechnology, and immunology to the diagnosis, treatment, monitoring and prevention of human diseases. The articles published also include those covering the analytical and molecular diagnostic techniques, instrumentation, data processing, quality assurance and accreditation aspects of the clinical investigations in which chemistry has played a major role, or laboratory animal studies with biochemical and clinical relevance.